Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,
View Top Employees from Modalis Therapeutics| Website | http://www.modalistx.com |
| Revenue | $19.2 million |
| Funding | $26 million |
| Employees | 42 (42 on RocketReach) |
| Founded | 2016 |
| Address | 51 Moulton St, Cambridge, Massachusetts 02138, US |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Life Science |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Modalis Therapeutics employee's phone or email?
Modalis Therapeutics Questions
The Modalis Therapeutics annual revenue was $19.2 million in 2024.
42 people are employed at Modalis Therapeutics.
Modalis Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Modalis Therapeutics are [325, 32, 3254].
The SIC codes for Modalis Therapeutics are [283, 28, 80].
Top Modalis Therapeutics Employees
-
12
-
12
-
1
-
31
-
21
-
View
Alison Walsh
Senior Scientist at Modalis Therapeutics
East Boston, Massachusetts, United States24 -
11
-
32
Related Companies
